The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), supports neuroscience investigators seeking to advance their biotherapeutic drug discovery and development projects into the clinic. Program Director Dr. Ann-Marie Broome provides an overview of the program and answer questions about the application process as we gear up for our first receipt date for the recently published funding opportunities listed below:
- PAR-21-163 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- PAR-21-233 Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Next Receipt date for both BPN-Biologics Funding Opportunities is February 9, 2022.
All investigators who are interested in learning about the BPN-Biologics program are encouraged to register and participate. While you can listen to the call on the phone, all questions will need to be submitted online. You can also submit questions before the meeting to Ms. Natasha Davis. We cannot guarantee that all questions will be answered, but will try to get to as many as possible within the timeframe.